 | Up a level |
Achtnichts, L; Chan, A; Czaplinski, A; Derfuss, T; Du Pasquier, R; Findling, O; Gobbi, C; Hoepner, R; Kamber, N; Kamm, C P; Kuhle, J; Lalive, P; Lutterotti, A; Martin, R; Müller, S; Papadopoulou, A; Pot, C; Salmen, A; Schippling, S and Zecca, C (2019). Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary. Clinical and translational neuroscience, 3(1), 2514183X1882207. Sage Publications 10.1177/2514183X18822073
Schippling, S; Balk, Lj; Costello, F; Albrecht, P; Balcer, L; Calabresi, Pa; Frederiksen, Jl; Frohman, E; Green, Aj; Klistorner, A; Outteryck, O; Paul, F; Plant, Gt; Traber, G; Vermersch, P; Villoslada, P; Wolf, Sebastian; Petzold, A (2015). Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Multiple sclerosis journal, 21(2), pp. 163-170. Sage 10.1177/1352458514538110
